Durvalumab vs Semaglutide

## Durvalumab vs Semaglutide: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Semaglutide**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Semaglutide**: GLP-1 receptor agonist with enhanced albumin binding for extended action.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Semaglutide — 7 days.

## Chemical Properties

**Type**: Durvalumab — Antibody; Semaglutide — Protein.